To further evaluate the clinical relevance of MRPS7 and MRPS23 in NPC, we performed IHC staining on tumor specimens from 41 patients who had received cisplatin (DDP)-based therapy (Table S1-3). The gene discussed is MRPS23; the disease is nasopharyngeal carcinoma.